deltatrials
Completed PHASE4 NCT00287508

Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study)

Emboshield and Xact Post Approval Carotid Stent Trial Using the Emboshield® BareWire™ Rapid Exchange Embolic Protection System and Xact® Rapid Exchange Carotid Stent System

Sponsor: Abbott Medical Devices

Conditions Atherosclerosis Carotid Artery Disease Carotid Stenosis Stroke
Interventions Carotid artery stenting with filter (interventional)
Updated 6 times since 2017 Last updated: Oct 16, 2008 Started: Nov 30, 2005 Primary completion: Dec 31, 2007 Completion: Jan 31, 2008

This PHASE4 trial investigates Atherosclerosis and Carotid Artery Disease and is currently completed. Abbott Medical Devices leads this study, which shows 6 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Dec 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jun 2018 — Dec 2018 [monthly]

    Completed PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Nov 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Abbott Medical Devices
Data source: Abbott Medical Devices

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.